GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Plans » Odontoprev SA (GREY:ODPVF) » Definitions » Cyclically Adjusted Revenue per Share

Odontoprev (Odontoprev) Cyclically Adjusted Revenue per Share : $0.00 (As of Mar. 2024)


View and export this data going back to 2012. Start your Free Trial

What is Odontoprev Cyclically Adjusted Revenue per Share?

Note: As Cyclically Adjusted Revenue per Share is a main component used to calculate Cyclically Adjusted PS Ratio. If the month end stock price for this stock is zero, result may not be accurate due to the exchange rate between different shares and the data will not be stored into our database. Selected historical data showed in the calculation section below is only for demostration purpose.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Odontoprev's adjusted revenue per share for the three months ended in Mar. 2024 was $0.213. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is $0.00 for the trailing ten years ended in Mar. 2024.

During the past 12 months, Odontoprev's average Cyclically Adjusted Revenue Growth Rate was 5.90% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 9.70% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 9.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Odontoprev was 10.50% per year. The lowest was 7.70% per year. And the median was 10.00% per year.

As of today (2024-06-10), Odontoprev's current stock price is $3.94. Odontoprev's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was $0.00. Odontoprev's Cyclically Adjusted PS Ratio of today is .

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Odontoprev was 6.93. The lowest was 2.38. And the median was 4.25.


Odontoprev Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for Odontoprev's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Odontoprev Cyclically Adjusted Revenue per Share Chart

Odontoprev Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Odontoprev Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Odontoprev's Cyclically Adjusted Revenue per Share

For the Healthcare Plans subindustry, Odontoprev's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Odontoprev's Cyclically Adjusted PS Ratio Distribution in the Healthcare Plans Industry

For the Healthcare Plans industry and Healthcare sector, Odontoprev's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Odontoprev's Cyclically Adjusted PS Ratio falls into.



Odontoprev Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Odontoprev's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0.213/159.3724*159.3724
=0.213

Current CPI (Mar. 2024) = 159.3724.

Odontoprev Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201406 0.236 91.838 0.410
201409 0.231 92.602 0.398
201412 0.215 94.194 0.364
201503 0.181 97.799 0.295
201506 0.181 100.006 0.288
201509 0.152 101.392 0.239
201512 0.156 104.247 0.238
201603 0.166 106.979 0.247
201606 0.185 108.851 0.271
201609 0.196 109.986 0.284
201612 0.192 110.802 0.276
201703 0.208 111.869 0.296
201706 0.203 112.115 0.289
201709 0.216 112.777 0.305
201712 0.201 114.068 0.281
201803 0.211 114.868 0.293
201806 0.186 117.038 0.253
201809 0.188 117.881 0.254
201812 0.211 118.340 0.284
201903 0.221 120.124 0.293
201906 0.218 120.977 0.287
201909 0.207 121.292 0.272
201912 0.209 123.436 0.270
202003 0.175 124.092 0.225
202006 0.157 123.557 0.203
202009 0.150 125.095 0.191
202012 0.165 129.012 0.204
202103 0.151 131.660 0.183
202106 0.171 133.871 0.204
202109 0.169 137.913 0.195
202112 0.160 141.992 0.180
202203 0.344 146.537 0.374
202206 0.175 149.784 0.186
202209 0.167 147.800 0.180
202212 0.174 150.207 0.185
202303 0.184 153.352 0.191
202306 0.211 154.519 0.218
202309 0.213 155.464 0.218
202312 0.212 157.148 0.215
202403 0.213 159.372 0.213

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


Odontoprev  (GREY:ODPVF) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Odontoprev was 6.93. The lowest was 2.38. And the median was 4.25.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Odontoprev Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of Odontoprev's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Odontoprev (Odontoprev) Business Description

Industry
Traded in Other Exchanges
Address
Avenida Marcos Penteado de Ulhoa Rodrigues, 939 - 14th Floor, section 1401, Jatoba Building, Castelo Branco Office Park, Tambore, Barueri, SP, BRA, 06460-040
Odontoprev SA provides dental benefit plans throughout Brazil and operates a sizable network of dentists throughout the country. The firm operates in three segments based on client size as well as one auxiliary segment that includes dental care goods and services. The dental care plan segments include corporate plans with many contracts (more than 200); small and midsize, with smaller groups of contracts; and individual, which includes monthly and annual plans sold directly to individuals. The majority of Odontoprev's revenue is generated by the corporate segment.

Odontoprev (Odontoprev) Headlines

From GuruFocus

Royce International Premier Fund Semiannual Letter

By Cody Eustice Cody Eustice 09-19-2016

Royce Investment Partners Comments on OdontoPrev

By Sydnee Gatewood Sydnee Gatewood 10-27-2020